Microbial contamination of multiple‐use bottles of fluorescein ophthalmic solution

REFERENCES

• Omolabake S. The synthesis of fluorescent 3, 6‐dihydroxyxanthones: a route to substituted Fluoresceins. 2016. Theses and Dissertations. Paper 1299.
   Google Scholar
• Lasnier O, Faucher A. Microbial and fungal contamination following a day use of multiple use bottles of fluoresceine sodium 0.25 per cent and benoxinate hydrochloride 0.4 per cent in an outpatient ophthalmology clinic. Invest Ophthalmol Vis Sci 2012; 53: 446.
   Google Scholar
• Micallef C, Cuschieri P. Ocular infections due to contaminated solutions. Ophthalmologica 2001; 215: 337–350.
   PubMed Web of Science ®Google Scholar
• Mayo MS, Schlitzer RL, Ward MA. Association of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol 1987; 25: 398–400.
   Web of Science ®Google Scholar
• Geyer O, Bottone EJ, Podos SM et al. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 1995; 79: 376–379.
   PubMed Web of Science ®Google Scholar
• Hovding G, Sjursen H. Bacterial contamination of drops and dropper tips of in use multidose eye drop bottles. Acta Ophthalmol 1982; 60: 213–222.
   PubMed Web of Science ®Google Scholar
• Tasli H, Cosar G. Microbial contamination of eye drops. Cent Eur J Public Health 2001; 9: 162–164.
   PubMedGoogle Scholar
• Schein OD, Wasson PJ, Boruchoff SA et al. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol 1988; 105: 361–365.
   Web of Science ®Google Scholar
• Teuchner B, Wagner J, Nikolaos E et al. Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital. Medicine (Baltimore) 2015; 94: e583.
   Web of Science ®Google Scholar
• Akiba M, Yoshida L, Akiba J et al. Microbial contamination of ophthalmic solutions in examination rooms. Jpn J Clin Ophthalmol 1996; 50: 411–414.
   Google Scholar
• Vaughan DG. Contamination of fluorescein solutions. Am J Ophthalmol 1955; 39: 55–61.
   Web of Science ®Google Scholar
• Claoué C. Experimental contamination of minims of fluorescein by Pseudomonas aeruginosa. Br J Ophthalmol 1986; 70: 507–509.
   Web of Science ®Google Scholar
• Duffner LR, Pflugfelder SC, Mandelbaum S et al. Potential bacterial contamination in fluorescein‐anesthetic solutions. Am J Ophthalmol 1990; 110: 199–202.
   PubMed Web of Science ®Google Scholar
• Leck AK, Thomas PA, Hagan M et al. Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002; 86: 1211–1215.
   PubMed Web of Science ®Google Scholar
• H‐kauffmann JD, Wormser PG, Nichols SN et al. Bacterial contamination of ophthalmic solutions used in an extended care facility. Br J Ophthalmol 2007; 91: 1308–1310.
   Web of Science ®Google Scholar
• Gloria A, Cheryl B, John E et al. Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world. Centers for Disease Control and Prevention and World Health Organization, Department of Communicable Disease Surveillance and Response, Atlanta, Ga, USA, 2003.
   Google Scholar
• Sharma S. Ocular Microbiology, 1st ed. Madurai: Aravind Eye Hospital Publication, 1988.
   Google Scholar
• Aldrich DS , Bach CM, Brown W et al. Ophthalmic Preparations—Quality Tests (771). USP 2013; 39, 11:04:44. [Cited 18 Jan 2018]. Available at: (P) \\Usp‐netapp2\share\SHARE\USPNF\PRINTQ\pager\xmlIn\NEP_20130828110441_S200824.xml
   Google Scholar
• Madigan M, Martinko J, eds. Brock Biology of Microorganisms, 13th ed. London, UK: Pearson Education, 2006. p. 1096.
   Google Scholar
• Jeglum EL, Rosenberg SB, Benson WE. Preparation of intravitreal drug doses. Ophthalmic Surg 1981; 12: 355–359.
   Google Scholar
• Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001, 2001; 79: 214–221.
   PubMed Web of Science ®Google Scholar
• Whitcher JP, Srinivasan M, Upadhyay MP. Prevention of corneal ulceration in the developing world. Int Ophthalmol Clin 2002; 42: 71–77.
   PubMedGoogle Scholar
• Upadhyay MP, Srinivasan M, Whitcher JP. Microbial keratitis in the developing world: does prevention work? Int Ophthalmol Clin 2007; 47: 17–25.
   PubMedGoogle Scholar
• Ubani UA. Bacteriology of external ocular infections in Aba, South Eastern Nigeria. Clin Exp Optom 2009; 92: 482–489.
   Web of Science ®Google Scholar
• Capriotti JA, Pelletier JS, Shah M et al. The etiology of infectious corneal ulceration in Sierra Leone. Int Ophthalmol 2010; 30: 637–640.
   Google Scholar
• Burton MJ, Pithuwa J, Okello E et al. Microbial keratitis in East Africa: why are the outcomes so poor? Ophthalmic Epidemiol 2010; 18: 158–163.
   Web of Science ®Google Scholar
• Schaftenaar E, van Gorp ECM, Meenken C et al. Ocular infections in sub‐Saharan Africa in the context of high HIV prevalence. Trop Med Int Health 2014; 19: 1003–1014.
   PubMed Web of Science ®Google Scholar
• Alarcon I, Tam C, Mun JJ et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci 2011; 52: 1368–1377.
   Web of Science ®Google Scholar
• Gyanfosu L, Koffuor GA, Kyei S et al. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans‐induced keratomycosis. Int Ophthalmol 2017; https://doi.org/10.1007/s10792-017-0707-z.
   Web of Science ®Google Scholar